Axsome Therapeutics ceo salary
Herriot Tabuteau, Chief Executive Officer, President and Chairman of the Board of Axsome Therapeutics, Inc. (AXSM), received $10,364,688 ($10.4M) in total compensation for FY2024, up 4.7% from the prior year. Option awards of $5,666,608 were the largest component. Figures come from Axsome Therapeutics, Inc.'s DEF 14A filed 25 Apr 2025 (accession 0000950170-25-058781).
Reported total from the latest DEF 14A pay table. Source filing (accession 0000950170-25-058781). These figures come from Axsome Therapeutics, Inc.'s DEF 14A filed 25 Apr 2025 (accession 0000950170-25-058781).
| Component | Amount |
|---|---|
| Salary | $780,000 |
| Stock awards | $2,833,150 |
| Option awards | $5,666,608 |
| Cash incentive | $955,500 |
| Other | $129,430 |
| Total | $10,364,688 |
FAQ
See also: AXSM ticker page